Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Cognitive Dysfunction in Schizophrenia
NCT02104752Phase 2Completed
- Sponsor
- VA Greater Los Angeles Healthcare System
- Start
- Jul 2014
- Primary completion
- May 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in schizophrenia, sponsored by VA Greater Los Angeles Healthcare System. Started Jul 2014; status: completed.
02
Drugs
curcumin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02104752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104752.